Best read of the week

 

Hospitals can preview CMS star ratings through December
Becker’s Hospital Review: CMS is making its preview of the February 2019 Hospital Compare star ratings and quality data available on QualityNet from Dec. 1 to Dec. 30.

Additional news media reports on MLH physicians and the health care industry, excerpted from MLH’s daily Morning News Report:

Main Line Health…

How a Mistaken Flu Diagnosis Almost Killed Steve Grandizio
Main Line Today: The Media native shares his harrowing health journey.

Regional News…

Telemedicine offers new health care possibilities – but payment challenges abound
Philly Voice: Telemedicine – the remote delivery of health care services via communication technologies – has been around for decades.

Health Business News…..
Trump Administration proposes using ACA subsidies to buy non-Obamacare health insurance
Healthcare Finance News: Democrats demand answers to what they call a sabotage of the ACA.

Quality and Safety News…
American Medical Association lays out new policy to combat physician suicide requiring data collection by key accrediting bodies
Healthcare Finance News: Policy asks Liaison Committee on Medical Education, Accreditation Council for Graduate Medical Education to gather data on physicians, students.

Patient Care News…
Outpatients for influenzalike illness above national baseline: 5 things to know
Becker’s Hospital Review: Outpatients visits for a flulike illness increased as of Nov. 24 in the 2018-19 flu season, according to the CDC’s most recent FluView report.

Posted in Clinician News | Tagged | Leave a comment

Heartfelt holiday wishes from MLH and holiday meal schedule

By Barbara Wadsworth, SVP, chief nursing officer, and Paul Yakulis, SVP, Human Resources

With the festive season upon us, on behalf of MLH leadership, we’d like to pause to say thank you for all that you have helped us accomplish this year. Together, we have achieved remarkable success in the face of an ever changing healthcare landscape and the many unique challenges presented on our journey to create a high-reliability and high-performing organization.

Without your unwavering dedication and support, our mission to improve the health of the communities we serve wouldn’t be possible. Your commitment to excellence this year and every year is what makes Main Line Health the best place to give and receive care.

Wishing you and your families a warm and peaceful holiday season and a very happy New Year.

Holiday Meals
In appreciation for all that you do for our patients and to celebrate the spirit of the season, holiday meals have been scheduled at the following locations across the system:

Campus-wide meals (to be provided at lunch, dinner and overnight)

  • Bryn Mawr Hospital – Friday, December 14 and Saturday, December 15
  • Bryn Mawr Rehab – Thursday, December 13 and Saturday, December 15
  • Lankenau Medical Center – Thursday, December 14 and Saturday, December 16
  • Paoli Hospital –Saturday, December 8
  • Riddle Hospital – Sunday, December 10

Catered meals will also be delivered to the following sites:

  • MTC Broomall  – Tuesday, December 11
  • Newtown Square – Tuesday, December 11
  • 306 Lancaster – Tuesday, December 11
  • Lawrence Park – Tuesday, December 11
  • Exton – Friday, December 14
  • Collegeville – Monday, December 10
  • Concordville – Friday, December 14
  • MTC Broomall – Tuesday, December 11
  • MTC Exton – Friday, December 14
  • Radnor  – Wednesday, December 12
  • Southpoint  – Thursday, December 13
  • Ellis Preserve MLH Healthcare – Tuesday, December 18
  • Ellis Preserve Finance – Wednesday, December 19

MLH Urgent Care sites will receive meals at lunch on Thanksgiving Day and Christmas Day:

  • Exton
  • Concordville
  • Broomall
  • Wynnewood
Posted in Clinician News | Tagged | Leave a comment

Infection Prevention planning for The Joint Commission (TJC)

By Mark Ingerman, MD & Eileen Sherman

TJC is planning visits to all five facilities of the Main Line Health System (MLHS) in the near future. These visits are unannounced surveys. There are several TJC standards from an Infection Prevention (IP) standpoint. The following are areas that will be highlighted for TJC strategic reviews.

  1. Hand Hygiene and Isolation: TJC standards require that all facilities maintain 100% compliance regarding hand hygiene. Please assure that all healthcare personnel comply with MLHS hand hygiene policies. This includes performing hand hygiene before and after leaving a patient’s room or having patient contact. TJC will cite any institution that does not maintain 100% compliance.

In addition, please abide by all isolation protocols. Isolation signs are maintained on the exterior of any patient’s room that requires a specific type of isolation. Whether the isolation is for droplet precautions, airborne precautions, contact precautions or special contact precautions, please maintain strict compliance with these policies. TJC will cite any deviations from the standard of care.

  1. Antimicrobial Stewardship (AMS): MLHS has a robust antimicrobial stewardship (AMS) program. This is a standard in which our system complies with the TJC. The choice of antibiotic therapy, as well as the duration of these medications, is monitored on a regular basis by infectious disease pharmacists, as well as general pharmacists educated in AMS. These pharmacists review the antibiotic usage throughout the MLHS on a regular basis. AMS education has been disseminated to system and campus CEWs and COCs.
  2. Device utilization: The Infection Prevention goal is to eliminate possible healthcare-associated infections (HAI) such as CAUTI, CLABSI, C. diff , SSIs, and VAPs. The most important element in preventing certain HAI is the removal of unnecessary devices such as central lines and Foley catheters when no longer clinically indicated. The more rapid these devices are removed, the less likely a patient will acquire a HAI which prolongs their hospital stay and increases the overall morbidity of the patient.

Our goal from an IP standpoint is to limit any infectious risks to our patients, improving the quality and safety of their stay at MLHS.

Should you have any questions, please contact either Dr. Mark Ingerman or Eileen Sherman.

 

Posted in Clinician News | Tagged | Leave a comment

Main Line HealthCare updates

Main Line HealthCare Welcomes:

NEW – MLHC Pain Management at Lankenau  
Soorena Khojasteh, MD

Victor I. Adamov, MD (inpt consult coverage only)
Lankenau Medical Center, MOB East, Suite 261

100 E. Lancaster Avenue, Wynnewood, PA  19096

610.658.1928 / www.mainlinehealth.org/mlhcpain

 

NEW – MLHC Primary Care in Media  
Christie O. Mousaw, DO

Flagship Corporate Center

2 W. Baltimore Avenue, Suite 101

Media, PA  19063

484.227.0900 / www.mainlinehealth.org/mediaprimary

 

Michael Carboine, PA-C

Lankenau Heart Group  / CT Surgery – Heart Pavilion

 

Marissa Carboine, PA-C  – (Paoli 484.527.2229)

Laura Eccles, CRNP  – (Bryn Mawr 610.525.1061)

MLH-Jefferson Neurosurgery

 

Kyle Engelbart, CRNP

MLHC Palliative Care at Paoli Hospital  484.565.2580

 

Physicians offering additional office locations:

Crystal Brogan, MD –OB/GYN

Also seeing patients at Springfield Square location

Thursday afternoons beginning 12/6/2018

965 Baltimore Pike, Suite 2-B

Springfield, PA  19064

For appointments:   610.642.7714

Posted in Clinician News | Tagged | Leave a comment

In memoriam: Frank J. Manfrey, DO

 We regret to inform you that Frank Manfrey, DO, passed away in November. He was on staff at Bryn Mawr and Paoli Hospitals and served as chair of the Department of Obstetrics and Gynecology. In lieu of flowers, the family asked that donations be made to the Neonatal Intensive Care Unit at Paoli Hospital.

Dr. Manfrey’s full obituary is attached or you may read it here: https://www.meaningfulfunerals.net/?action=obituaries.obit_view&CFID=fe5e1903-7e6b-4dba-b9ef-64d00bbb0a0a&CFTOKEN=0&o_id=5596792&fh_id=14125

Posted in Clinician News | Tagged | Leave a comment

Mirmont Treatment Center designated an Aetna Institute of Quality®

Mirmont Treatment Center has been designated an Aetna Institute of Quality® for Behavioral Health—Substance Abuse. Aetna makes information about the quality and cost of health care services available to its members to help them make informed decisions about their health care needs. In line with this goal, Aetna recognizes facilities in its network that offer specialized clinical services for certain health conditions. Facilities are selected for exemplifying:

  • Excellence in care
  • Commitment to continuous improvement
  • Meeting certain standards of quality
  • Cost efficiency

“We are honored by Aetna’s acknowledgement, which further demonstrates Mirmont’s ability to provide high quality care to our patients and community members,” says Tom Cain, President of Mirmont Treatment Center. “This designation is an important achievement not only for the staff of Mirmont, but for the patients we treat – and their families – who we help combat addiction and return to a normal life after recovery.”

Aetna recognizes facilities that have earned this designation by identifying them in the directory as an Institute of Quality provider. This designation helps members choose consistent high quality care.

Posted in Clinician News | Tagged | Leave a comment

Main Line Health Named to CHIME HealthCare’s 2018 Most Wired

For the 10th consecutive year, Main Line Health (MLH) was named to CHIME HealthCare’s Most Wired list for 2018.  Most Wired is celebrating its 20th year as the industry’s benchmark of quality in health care IT, and its first year under the College of Healthcare Information Management Executives (CHIME).

“Being recognized one again as ‘Most Wired’ exemplifies Main Line Health’s commitment to staying well ahead in strategic information technology in an effort to provide a superior patient experience,” explained Kay Carr, Senior Vice President and Chief Information Officer at Main Line Health. “Our long-term strategic investment in information technology complements our ongoing enhancements in care quality, safety and state-of-the-art facilities.”

As a Most Wired health system, MLH has integrated technology in every facet of the health care delivery system, including launching Epic last spring as MLH’s comprehensive clinical and business platform. Through the Epic project and parallel initiatives, MLH is working to transform the way care is delivered across the health system.

“Most Wired is a tribute to the organizations and dedicated people in them who are transforming health care and improving patient outcomes,” said Russell Branzell, CHIME president.  “Thanks to our 2018 participants, we are raising the standards of care – and saving lives.”

Click here for the 2018 Most Wired report.

Posted in Clinician News | Tagged | Leave a comment

Diversity & Inclusion holiday observances

Click here for the holidays celebrated in the month of December. A monthly calendar of Diversity & Inclusion events can be viewed on the Diversity & Inclusion intranet page.

Posted in Clinician News | Tagged | Leave a comment

STEEEP Huddle: E for Equitable

This week’s STEEEP Huddle topicsubmitted by Michael Miller, manager, Workers’ Compensation and Employee Safety, focuses on Temporary Alternative Duty (TAD), a MLH policy that provides modified work to employees while they recover from their on-the-job injury.  Last year, 177 MLH employees were accommodated under TAD and provided 7,611 days of meaningful work to MLH. Adherence to MLH’s TAD policy supports an equitable work environment by providing accommodations to employees who suffer an on-the-job injury. Managers and leaders support an equitable work environment by providing TAD to their employees who have suffered injury.

The STEEEP Huddle topics are posted on the Performance Excellence 2020 site at landing.mainlinehealth.org/PE2020.

Posted in Clinician News | Tagged | Leave a comment

Clinical Trial of the Week: Treatment trial for men with localized intermediate-risk prostate cancer

By Donna Loyle, communications specialist, LIMR

Main Line Health researchers are conducting a treatment trial for men diagnosed with stage IIA-B prostate cancer. Study #NRG GU005 is a phase III clinical trial that seeks to determine the safety and efficacy of stereotactic body radiation therapy (SBRT) vs. hypofractionated intensity-modulated radiation therapy (IMRT).

SBRT is a specialized radiation therapy that sends X-rays directly to the tumor using smaller doses over several days and may cause less damage to normal tissue. IMRT uses linear accelerators to deliver precise radiation doses to a tumor while minimizing the dose to surrounding normal tissue.

SBRT is a specialized radiation therapy that sends X-rays directly to the tumor using smaller doses over several days and may cause less damage to normal tissue. IMRT uses linear accelerators to deliver precise radiation doses to a tumor while minimizing the dose to surrounding normal tissue.SBRT is a specialized radiation therapy that sends X-rays directly to the tumor using smaller doses over several days and may cause less damage to normal tissue. IMRT uses linear accelerators to deliver precise radiation doses to a tumor while minimizing the dose to surrounding normal tissue.

Patients are randomized into two study arms: One group undergoes IMRT once daily over less than 32 business days. The other group undergoes SBRT at least every other day over less than 12 business days. Patients must agree to follow-up care for two years after therapy.

Inclusion criteria:

  • Previously untreated localized adenocarcinoma of the prostate with the following clinical findings: clinical stage by DRE of either T1c or T2a/b (limited to one side of the gland; AJCC version 7) or cT1a-c or 2a or 2b, stage group IIA or IIB (AJCC, version 8).
  • Stages T1a-T1b eligible if patient underwent TURP previously. Gleason score must be 7(3+4) with a PSA < 20 ng/mL, or 6(3+3) with a PSA > 10 ng/mL and < 20 ng/mL; (AJCC, version 7) or group grade 1 or 2, stage group IIA or IIB (AJCC version 8).
  • Prostate volume must be < 60 cc as reported at time of biopsy or by separate measure.

To date, this study has enrolled 65 patients nationwide, four of which are from Main Line Health. The trial is available at Lankenau Medical Center and Paoli Hospital. Principal investigators are Albert DeNittis, MD, and Paul Gilman, MD. For more information, visit https://www.mainlinehealth.org/research/clinical-trials/nrg-gu005

 

Posted in Clinician News | Tagged | Leave a comment